Skip to main content
. Author manuscript; available in PMC: 2013 Oct 19.
Published in final edited form as: J Clin Oncol. 2008 Apr 1;26(10):1742–1751. doi: 10.1200/JCO.2007.12.1178

Table 1. Published crystal structures of EGFR-TK.

The table documents the EGFR-TK crystal structures currently published, including two recent EGFR-TK crystal structures in complex with anilinoquinazoline-based irreversible inhibitors 13-JAB and 34-JAB74.

Protein
Data
Bank
accession
code
Mutation Inhibitor Conformational
State
Space
Group
Resolution
limit (Å2)
Publication
1M14 Wild-Type --- active I23 2.6 Stamos (2002)
1M17 Wild-Type erlotinib (Tarceva) active I23 2.6 Stamos (2002)
1XKK Wild-Type lapatinib (Tykerb) inactive P212121 2.4 Wood (2004)
2GS6 Wild-Type ATP analogue-peptide conjugate active I23 2.6 Zhang (2006)
2GS2 Wild-Type --- active I23 2.8 Zhang (2006)
2GS7 V924R AMP-PNP inactive P21 2.6 Zhang (2006)
2ITX Wild-Type AMP-PNP active I23 3.0 Yun (2007)
2J6M Wild-Type gefitinib (Iressa) active I23 3.1 Yun (2007)
2ITW Wild-Type AFN-941 active I23 2.9 Yun (2007)
2ITY Wild-Type gefitinib (Iressa) active I23 3.4 Yun (2007)
2ITN G719S AMP-PNP active I23 2.4 Yun (2007)
2ITO G719S gefitinib (Iressa) active I23 3.2 Yun (2007)
2ITP G719S AEE788 active I23 2.7 Yun (2007)
2ITQ G719S AFN-941 active I23 2.7 Yun (2007)
2ITT L858R AEE-788 active I23 2.7 Yun (2007)
2ITU L858R AFN-941 active I23 2.8 Yun (2007)
2ITV L858R AMP-PNP active I23 2.4 Yun (2007)
2ITZ L858R gefitinib (Iressa) active I23 2.8 Yun (2007)
2J5E Wild-Type 13-JAB active I23 3.1 Blair (2007)
2J5F Wild-Type 34-JAB active I23 2.95 Blair (2007)